EBV-Positive B-Cell Proliferations of Varied Malignant Potential
- 24 February 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in American Journal of Clinical Pathology
- Vol. 147 (2), 129-152
- https://doi.org/10.1093/ajcp/aqw214
Abstract
Objectives: The 2015 Workshop of the Society for Hematopathology/European Association for Haematopathology aimed to review B-cell proliferations of varied malignant potential associated with immunodeficiency. Methods: The Workshop Panel reviewed all cases of B-cell hyperplasias, polymorphic B-lymphoproliferative disorders, Epstein-Barr virus (EBV)–positive mucocutaneous ulcer, and large B-cell proliferations associated with chronic inflammation and rendered consensus diagnoses. Disease definitions, boundaries with more aggressive B-cell proliferations, and association with EBV were explored. Results: B-cell proliferations of varied malignant potential occurred in all immunodeficiency backgrounds. Presentation early in the course of immunodeficiency and in younger age groups and regression with reduction of immunosuppression were characteristic features. EBV positivity was essential for diagnosis in some hyperplasias where other specific defining features were absent. Conclusions: This spectrum of B-cell proliferations show similarities across immunodeficiency backgrounds. Localized forms of immunodeficiency disorders arise in immunocompetent patients most likely due to chronic immune stimulation and, despite aggressive histologic features, often show indolent clinical behavior.Keywords
This publication has 73 references indexed in Scilit:
- Epstein-Barr virus–positive mucocutaneous ulcer of the oral cavity: the importance of having a detailed clinical history to reach a correct diagnosisOral Surgery, Oral Medicine, Oral Pathology and Oral Radiology, 2012
- Polymorphic lymphoid proliferations occurring in HIV-positive patients: report of a case responding to HAARTVirchows Archiv, 2012
- EBV+ diffuse large B-cell lymphoma arising within atrial myxoma. An example of a distinct primary cardiac EBV+ DLBCL of immunocompetent patientsPathology - Research and Practice, 2012
- Risk of lymphoma in patients receiving antitumor necrosis factor therapy: a meta-analysis of published randomized controlled studiesClinical Rheumatology, 2011
- Age-related EBV-associated lymphoproliferative disorders in the Western population: a spectrum of reactive lymphoid hyperplasia and lymphomaBlood, 2011
- Epstein-Barr Virus-associated Diffuse Large B-cell Lymphoma Arising on Cardiac ProsthesesThe American Journal of Surgical Pathology, 2010
- Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008Annals Of Oncology, 2009
- EBV‐associated diffuse large B‐cell lymphoma arising in the chest wall with surgical mesh implantPathology International, 2008
- Genetic and phenotypic analysis of B‐cell post‐transplant lymphoproliferative disorders provides insights into disease biologyHematological Oncology, 2008
- Oral effects of low-dose methotrexate treatmentOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2005